Predict your next investment

HEALTHCARE | Biotechnology
cellartis.com

See what CB Insights has to offer

Founded Year

2001

Stage

Acquired | Acquired

Total Raised

$16.02M

About Cellartis

Provider of human embryonic stem (hES) cell-based products and technologies. The company provides characterized hES cell lines, culture media, tools, feeder cells, and training courses to clinical researchers worldwide. Its primary focus is on drug discovery applications and toxicity testing based on hES cells.

Cellartis Headquarter Location

Biotech Center Arvid Wallgrens Backe 20

Gothenburg, 413 46,

Sweden

46 31 758 09 00

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cellartis Patents

Cellartis has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/18/2008

2/10/2015

Drug discovery, Developmental biology, Embryology, Transcription factors, Stem cells

Grant

Application Date

7/18/2008

Grant Date

2/10/2015

Title

Related Topics

Drug discovery, Developmental biology, Embryology, Transcription factors, Stem cells

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.